{"component": "clause", "props": {"groups": [{"size": 18, "samples": [{"hash": "8JfImJE3rPH", "uri": "/contracts/8JfImJE3rPH#formation-composition", "label": "Collaboration Agreement (Reata Pharmaceuticals Inc)", "score": 27.1026687622, "published": true}, {"hash": "fOR6XG4rhlO", "uri": "/contracts/fOR6XG4rhlO#formation-composition", "label": "Collaboration Agreement (Reata Pharmaceuticals Inc)", "score": 26.8836421967, "published": true}], "snippet_links": [{"key": "the-parties-shall", "type": "clause", "offset": [0, 17]}, {"key": "joint-executive-committee", "type": "definition", "offset": [30, 55]}, {"key": "each-party", "type": "clause", "offset": [69, 79]}, {"key": "applicable-party", "type": "definition", "offset": [203, 219]}, {"key": "scope-of-the", "type": "clause", "offset": [257, 269]}, {"key": "initial-representatives", "type": "clause", "offset": [307, 330]}, {"key": "on-schedule", "type": "definition", "offset": [356, 367]}, {"key": "from-time-to-time", "type": "clause", "offset": [401, 418]}, {"key": "consent-of", "type": "clause", "offset": [429, 439]}, {"key": "consultants-and-advisors", "type": "clause", "offset": [495, 519]}, {"key": "a-party", "type": "clause", "offset": [523, 530]}, {"key": "obligation-of-confidentiality", "type": "clause", "offset": [548, 577]}, {"key": "consistent-with", "type": "definition", "offset": [578, 593]}, {"key": "this-agreement", "type": "clause", "offset": [594, 608]}, {"key": "participate-in", "type": "definition", "offset": [613, 627]}, {"key": "meetings-of-the", "type": "clause", "offset": [648, 663]}, {"key": "provided-that", "type": "definition", "offset": [669, 682]}, {"key": "voting-authority", "type": "clause", "offset": [715, 731]}, {"key": "term-of", "type": "clause", "offset": [800, 807]}, {"key": "one-year", "type": "definition", "offset": [808, 816]}, {"key": "annual-basis", "type": "definition", "offset": [863, 875]}, {"key": "the-chairperson", "type": "clause", "offset": [962, 977]}, {"key": "to-ensure", "type": "clause", "offset": [1071, 1080]}, {"key": "preparation-of", "type": "clause", "offset": [1085, 1099]}, {"key": "additional-powers", "type": "clause", "offset": [1143, 1160]}, {"key": "vice-chairperson", "type": "clause", "offset": [1244, 1260]}, {"key": "the-vice", "type": "clause", "offset": [1492, 1500]}, {"key": "to-consult", "type": "definition", "offset": [1522, 1532]}, {"key": "assist-the", "type": "clause", "offset": [1542, 1552]}], "snippet": "The Parties shall establish a Joint Executive Committee (the \u201cJEC\u201d). Each Party shall initially appoint up to three (3) representatives to the JEC, each of whom will have sufficient seniority within the applicable Party to make decisions arising within the scope of the JEC\u2019s responsibilities. The Parties\u2019 initial representatives to the JEC are set forth on Schedule 2.3. The JEC may change its size from time to time by mutual consent of its members. The JEC may invite non-members (including consultants and advisors of a Party who are under an obligation of confidentiality consistent with this Agreement) to participate in the discussions and meetings of the JEC, provided that such participants shall have no voting authority at the JEC. The JEC shall have a chairperson, who shall serve for a term of one year, and who shall be selected alternately, on an annual basis, by Reata or \u2587\u2587\u2587\u2587\u2587\u2587. The initial chairperson shall be selected by \u2587\u2587\u2587\u2587\u2587\u2587. The role of the chairperson shall be to convene and preside at meetings of the JEC, to prepare and circulate agendas and to ensure the preparation of minutes, but the chairperson shall have no additional powers or rights beyond those held by the other JEC representatives. The JEC shall have a vice chairperson, who shall serve for a term of one year (and who then shall serve as chairperson), and who shall be selected alternately, on an annual basis, by \u2587\u2587\u2587\u2587\u2587\u2587 or Reata. The initial vice chairperson shall be selected by Reata. The role of the vice chairperson shall be to consult with and assist the chairperson in the carrying out of the chairperson\u2019s duties.", "hash": "d4f0cd70041c37d254cd580c27d825a9", "id": 1}, {"size": 16, "samples": [{"hash": "5fYxm5NC39d", "uri": "/contracts/5fYxm5NC39d#formation-composition", "label": "Option, License and Collaboration Agreement (Gilead Sciences Inc)", "score": 30.8425731659, "published": true}, {"hash": "e5sUJ2ZVH0r", "uri": "/contracts/e5sUJ2ZVH0r#formation-composition", "label": "Option, License and Collaboration Agreement (Galapagos Nv)", "score": 30.6563987732, "published": true}], "snippet_links": [{"key": "after-the-effective-date", "type": "clause", "offset": [20, 44]}, {"key": "the-parties-shall", "type": "clause", "offset": [46, 63]}, {"key": "joint-development-committee", "type": "definition", "offset": [76, 103]}, {"key": "the-responsibilities", "type": "clause", "offset": [167, 187]}, {"key": "each-party", "type": "clause", "offset": [217, 227]}, {"key": "having-knowledge", "type": "definition", "offset": [315, 331]}, {"key": "development-of", "type": "clause", "offset": [353, 367]}, {"key": "similar-to", "type": "definition", "offset": [402, 412]}, {"key": "such-party", "type": "clause", "offset": [538, 548]}, {"key": "scope-of-the", "type": "clause", "offset": [586, 598]}, {"key": "from-time-to-time", "type": "clause", "offset": [651, 668]}, {"key": "agreed-by", "type": "definition", "offset": [672, 681]}, {"key": "provided-that", "type": "definition", "offset": [711, 724]}, {"key": "at-all-times", "type": "definition", "offset": [747, 759]}, {"key": "representatives-of", "type": "clause", "offset": [782, 800]}, {"key": "at-any-time", "type": "clause", "offset": [878, 889]}, {"key": "notice-to-the", "type": "clause", "offset": [903, 916]}, {"key": "other-party", "type": "definition", "offset": [917, 928]}, {"key": "either-party", "type": "definition", "offset": [930, 942]}, {"key": "participate-in", "type": "definition", "offset": [969, 983]}, {"key": "meetings-of-the-jdc", "type": "clause", "offset": [1004, 1023]}, {"key": "subject-to", "type": "clause", "offset": [1102, 1112]}, {"key": "confidentiality-obligations", "type": "clause", "offset": [1113, 1140]}, {"key": "article-xiii", "type": "clause", "offset": [1185, 1197]}, {"key": "voting-authority", "type": "clause", "offset": [1215, 1231]}, {"key": "term-of", "type": "clause", "offset": [1300, 1307]}, {"key": "annual-basis", "type": "definition", "offset": [1367, 1379]}, {"key": "the-chairperson", "type": "clause", "offset": [1471, 1486]}, {"key": "additional-powers", "type": "clause", "offset": [1577, 1594]}], "snippet": "Within [\u2026***\u2026] days after the Effective Date, the Parties shall establish a joint development committee (the \u201cJoint Development Committee\u201d or \u201cJDC\u201d), which shall have the responsibilities set forth in Section 1.2(b). Each Party shall initially appoint three (3) representatives to the JDC, with each representative having knowledge and expertise in the development of compounds, Molecules and products similar to the Galapagos Molecules, Galapagos Products, Optioned Molecules and Optioned Products and having sufficient seniority within such Party to make decisions arising within the scope of the JDC\u2019s responsibilities. The JDC may change its size from time to time if agreed by consensus among its members; provided that the JDC shall consist at all times of an equal number of representatives of each of Galapagos and Gilead. Each Party may replace its JDC representatives at any time upon written notice to the other Party. Either Party may invite non-members to participate in the discussions and meetings of the JDC provided notice is given to the other Party and such non-members shall (i) be subject to confidentiality obligations at least as stringent as those set forth in ARTICLE XIII and (ii) have no voting authority at the JDC. The JDC shall have a chairperson, who shall serve for a term of one (1) year, and who shall be selected alternately, on an annual basis, by Galapagos or Gilead. The initial chairperson shall be selected by [\u2026***\u2026]. The role of the chairperson shall be to convene and preside at meetings of the JDC, but the chairperson shall have no additional powers or rights beyond those held by the other JDC representatives.", "hash": "b6240b83742c0ddf029e3e5984b166d2", "id": 2}, {"size": 11, "samples": [{"hash": "5FakLyB0nmv", "uri": "/contracts/5FakLyB0nmv#formation-composition", "label": "Collaboration Agreement (Surface Oncology, Inc.)", "score": 29.2217655182, "published": true}, {"hash": "a77nconioih", "uri": "/contracts/a77nconioih#formation-composition", "label": "Collaboration Agreement (Surface Oncology, Inc.)", "score": 29.1724853516, "published": true}, {"hash": "6quj7ED1kuV", "uri": "/contracts/6quj7ED1kuV#formation-composition", "label": "Collaboration Agreement (Surface Oncology, Inc.)", "score": 28.8767967224, "published": true}], "snippet_links": [{"key": "each-party-will", "type": "clause", "offset": [0, 15]}, {"key": "having-knowledge", "type": "definition", "offset": [93, 109]}, {"key": "commercialization-of-products", "type": "clause", "offset": [131, 160]}, {"key": "similar-to", "type": "definition", "offset": [161, 171]}, {"key": "regional-licensed-products", "type": "clause", "offset": [176, 202]}, {"key": "applicable-party", "type": "definition", "offset": [246, 262]}, {"key": "scope-of-the", "type": "clause", "offset": [300, 312]}, {"key": "from-time-to-time", "type": "clause", "offset": [365, 382]}, {"key": "consent-of", "type": "clause", "offset": [393, 403]}, {"key": "provided-that", "type": "definition", "offset": [417, 430]}, {"key": "at-all-times", "type": "definition", "offset": [452, 464]}, {"key": "representatives-of", "type": "clause", "offset": [487, 505]}, {"key": "at-any-time", "type": "clause", "offset": [583, 594]}, {"key": "notice-to-the", "type": "clause", "offset": [608, 621]}, {"key": "other-party", "type": "definition", "offset": [622, 633]}, {"key": "participate-in", "type": "definition", "offset": [669, 683]}, {"key": "meetings-of-the-jcc", "type": "clause", "offset": [704, 723]}, {"key": "voting-authority", "type": "clause", "offset": [765, 781]}, {"key": "obligation-of-confidentiality", "type": "clause", "offset": [821, 850]}, {"key": "of-the-parties", "type": "clause", "offset": [870, 884]}, {"key": "confidential-information", "type": "definition", "offset": [886, 910]}, {"key": "in-this-agreement", "type": "definition", "offset": [932, 949]}, {"key": "by-novartis", "type": "clause", "offset": [1043, 1054]}, {"key": "conducting-meetings", "type": "clause", "offset": [1092, 1111]}, {"key": "responsibility-for", "type": "clause", "offset": [1203, 1221]}, {"key": "the-first-meeting", "type": "definition", "offset": [1355, 1372]}, {"key": "this-exhibit", "type": "definition", "offset": [1407, 1419]}, {"key": "replaced-with", "type": "clause", "offset": [1437, 1450]}, {"key": "the-secretary", "type": "clause", "offset": [1526, 1539]}, {"key": "the-securities-and-exchange-commission", "type": "clause", "offset": [1543, 1581]}, {"key": "confidential-treatment", "type": "definition", "offset": [1620, 1642]}, {"key": "pursuant-to-rule", "type": "clause", "offset": [1643, 1659]}, {"key": "securities-act-of-1933", "type": "clause", "offset": [1686, 1708]}, {"key": "as-amended", "type": "definition", "offset": [1710, 1720]}], "snippet": "Each Party will initially appoint [***] representatives to the JCC, with each representative having knowledge and expertise in the commercialization of products similar to the Regional Licensed Products and having sufficient seniority within the applicable Party to make decisions arising within the scope of the JCC\u2019s responsibilities. The JCC may change its size from time to time by mutual consent of its members, provided that the JCC will consist at all times of an equal number of representatives of each of Surface and Novartis. Each Party may replace its JCC representatives at any time upon written notice to the other Party. The JCC may invite non-members to participate in the discussions and meetings of the JCC, provided that such participants have no voting authority at the JCC and are bound under written obligation of confidentiality no less protective of the Parties\u2019 Confidential Information than those set forth in this Agreement. The JCC will be co-chaired, with one chairperson designated by Surface and [***] designated by Novartis, whose responsibilities will include conducting meetings, including, when feasible, ensuring that objectives for each meeting are set and achieved. Responsibility for running each meeting of the JCC will alternate between the chairpersons from meeting-to-meeting, with Novartis\u2019s chairperson running the first meeting. CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH \u201c[***]\u201d. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.", "hash": "57237a2906963ff29fe2e102f35bdf48", "id": 3}, {"size": 7, "samples": [{"hash": "k6ErdxlKAzH", "uri": "/contracts/k6ErdxlKAzH#formation-composition", "label": "Research, Collaboration & License Agreement (Ultragenyx Pharmaceutical Inc.)", "score": 29.1396312714, "published": true}, {"hash": "hMlSG6sauj", "uri": "/contracts/hMlSG6sauj#formation-composition", "label": "Research, Collaboration & License Agreement (Dimension Therapeutics, Inc.)", "score": 28.1841201782, "published": true}, {"hash": "4vQHfBpSR1D", "uri": "/contracts/4vQHfBpSR1D#formation-composition", "label": "Research, Collaboration & License Agreement (Dimension Therapeutics, Inc.)", "score": 27.6091709137, "published": true}], "snippet_links": [{"key": "the-effective-date", "type": "clause", "offset": [18, 36]}, {"key": "the-parties-will", "type": "clause", "offset": [38, 54]}, {"key": "joint-steering-committee", "type": "clause", "offset": [67, 91]}, {"key": "comprised-of", "type": "definition", "offset": [134, 146]}, {"key": "each-party", "type": "clause", "offset": [176, 186]}, {"key": "applicable-party", "type": "definition", "offset": [224, 240]}, {"key": "scope-of-the", "type": "clause", "offset": [278, 290]}, {"key": "from-time-to-time", "type": "clause", "offset": [343, 360]}, {"key": "consent-of", "type": "clause", "offset": [371, 381]}, {"key": "provided-that", "type": "definition", "offset": [395, 408]}, {"key": "at-all-times", "type": "definition", "offset": [430, 442]}, {"key": "representatives-of", "type": "clause", "offset": [454, 472]}, {"key": "jsc-representatives", "type": "clause", "offset": [527, 546]}, {"key": "at-any-time", "type": "clause", "offset": [547, 558]}, {"key": "notice-to-the", "type": "clause", "offset": [572, 585]}, {"key": "other-party", "type": "definition", "offset": [586, 597]}], "snippet": "Within [\u2026***\u2026] of the Effective Date, the Parties will establish a joint steering committee (the \u201cJoint Steering Committee\u201d or \u201cJSC\u201d) comprised of [\u2026***\u2026] representatives from each Party with sufficient seniority within the applicable Party to make decisions arising within the scope of the JSC\u2019s responsibilities. The JSC may change its size from time to time by mutual consent of its members, provided that the JSC will consist at all times of [\u2026***\u2026] representatives of each of Penn and Licensee. Each Party may replace its JSC representatives at any time upon written notice to the other Party.", "hash": "05c28bd47c03fbee8c02abbef2732b25", "id": 4}, {"size": 6, "samples": [{"hash": "5fYxm5NC39d", "uri": "/contracts/5fYxm5NC39d#formation-composition", "label": "Option, License and Collaboration Agreement (Gilead Sciences Inc)", "score": 30.8425731659, "published": true}, {"hash": "e5sUJ2ZVH0r", "uri": "/contracts/e5sUJ2ZVH0r#formation-composition", "label": "Option, License and Collaboration Agreement (Galapagos Nv)", "score": 30.6563987732, "published": true}], "snippet_links": [{"key": "joint-steering-committee", "type": "clause", "offset": [31, 55]}, {"key": "the-responsibilities", "type": "clause", "offset": [116, 136]}, {"key": "each-party", "type": "clause", "offset": [166, 176]}, {"key": "such-party", "type": "clause", "offset": [288, 298]}, {"key": "scope-of-the", "type": "clause", "offset": [336, 348]}, {"key": "commercialization-and-manufacturing", "type": "clause", "offset": [469, 504]}, {"key": "the-parties-shall", "type": "clause", "offset": [506, 523]}, {"key": "initial-representatives", "type": "clause", "offset": [562, 585]}, {"key": "after-the-effective-date", "type": "clause", "offset": [626, 650]}, {"key": "from-time-to-time", "type": "clause", "offset": [680, 697]}, {"key": "agreed-by", "type": "definition", "offset": [701, 710]}, {"key": "provided-that", "type": "definition", "offset": [740, 753]}, {"key": "at-all-times", "type": "definition", "offset": [776, 788]}, {"key": "representatives-of", "type": "clause", "offset": [811, 829]}, {"key": "jsc-representatives", "type": "clause", "offset": [887, 906]}, {"key": "at-any-time", "type": "clause", "offset": [907, 918]}, {"key": "notice-to-the", "type": "clause", "offset": [932, 945]}, {"key": "other-party", "type": "definition", "offset": [946, 957]}, {"key": "either-party", "type": "definition", "offset": [959, 971]}, {"key": "participate-in", "type": "definition", "offset": [998, 1012]}, {"key": "meetings-of-the-jsc", "type": "clause", "offset": [1033, 1052]}, {"key": "subject-to", "type": "clause", "offset": [1132, 1142]}, {"key": "confidentiality-obligations", "type": "clause", "offset": [1143, 1170]}, {"key": "article-xiii", "type": "clause", "offset": [1215, 1227]}, {"key": "voting-authority", "type": "clause", "offset": [1245, 1261]}, {"key": "term-of", "type": "clause", "offset": [1330, 1337]}, {"key": "annual-basis", "type": "definition", "offset": [1397, 1409]}, {"key": "the-chairperson", "type": "clause", "offset": [1501, 1516]}, {"key": "additional-powers", "type": "clause", "offset": [1603, 1620]}], "snippet": "The Parties hereby establish a joint steering committee (the \u201cJoint Steering Committee\u201d or \u201cJSC\u201d), which shall have the responsibilities set forth in Section 1.1(b). Each Party shall initially appoint four (4) representatives to the JSC, all of whom will have sufficient seniority within such Party to make decisions arising within the scope of the JSC\u2019s responsibilities and each of whom shall have experience in one of the following functions: research, development, commercialization and manufacturing. The Parties shall notify each other of their respective initial representatives to the JSC within [\u2026***\u2026] Business Days after the Effective Date. The JSC may change its size from time to time if agreed by consensus among its members; provided that the JSC shall consist at all times of an equal number of representatives of each of Galapagos and Gilead. Each Party may replace its JSC representatives at any time upon written notice to the other Party. Either Party may invite non-members to participate in the discussions and meetings of the JSC provided notice is given to the other Party, and such non-members shall (i) be subject to confidentiality obligations at least as stringent as those set forth in ARTICLE XIII and (ii) have no voting authority at the JSC. The JSC shall have a chairperson, who shall serve for a term of one (1) year, and who shall be selected alternately, on an annual basis, by Galapagos or Gilead. The initial chairperson shall be selected by [\u2026***\u2026]. The role of the chairperson shall be to convene and preside at meetings of the JSC. The chairperson shall have no additional powers or rights beyond those held by the other JSC representatives.", "hash": "fcb4ac4b7b387c7439807630ae929bbc", "id": 5}, {"size": 6, "samples": [{"hash": "6qM2tpMtTrx", "uri": "/contracts/6qM2tpMtTrx#formation-composition", "label": "Option, License and Collaboration Agreement (Arcus Biosciences, Inc.)", "score": 31.5954818726, "published": true}], "snippet_links": [{"key": "after-the-effective-date", "type": "clause", "offset": [18, 42]}, {"key": "the-parties-shall", "type": "clause", "offset": [44, 61]}, {"key": "joint-development-committee", "type": "definition", "offset": [74, 101]}, {"key": "the-responsibilities", "type": "clause", "offset": [165, 185]}, {"key": "each-party", "type": "clause", "offset": [215, 225]}, {"key": "having-knowledge", "type": "definition", "offset": [313, 329]}, {"key": "development-of", "type": "clause", "offset": [351, 365]}, {"key": "similar-to", "type": "definition", "offset": [389, 399]}, {"key": "such-party", "type": "clause", "offset": [517, 527]}, {"key": "scope-of-the", "type": "clause", "offset": [565, 577]}, {"key": "from-time-to-time", "type": "clause", "offset": [630, 647]}, {"key": "agreed-by", "type": "definition", "offset": [651, 660]}, {"key": "provided-that", "type": "definition", "offset": [690, 703]}, {"key": "at-all-times", "type": "definition", "offset": [726, 738]}, {"key": "representatives-of", "type": "clause", "offset": [761, 779]}, {"key": "at-any-time", "type": "clause", "offset": [853, 864]}, {"key": "notice-to-the", "type": "clause", "offset": [878, 891]}, {"key": "other-party", "type": "definition", "offset": [892, 903]}, {"key": "either-party", "type": "definition", "offset": [905, 917]}, {"key": "participate-in", "type": "definition", "offset": [944, 958]}, {"key": "meetings-of-the-jdc", "type": "clause", "offset": [979, 998]}, {"key": "prior-approval", "type": "definition", "offset": [1022, 1036]}, {"key": "subject-to", "type": "clause", "offset": [1142, 1152]}, {"key": "confidentiality-obligations", "type": "clause", "offset": [1153, 1180]}, {"key": "article-xiii", "type": "clause", "offset": [1225, 1237]}, {"key": "voting-authority", "type": "clause", "offset": [1255, 1271]}, {"key": "term-of", "type": "clause", "offset": [1340, 1347]}, {"key": "annual-basis", "type": "definition", "offset": [1407, 1419]}, {"key": "by-arcus", "type": "clause", "offset": [1421, 1429]}, {"key": "the-chairperson", "type": "clause", "offset": [1505, 1520]}, {"key": "additional-powers", "type": "clause", "offset": [1611, 1628]}], "snippet": "Within [***] days after the Effective Date, the Parties shall establish a joint development committee (the \u201cJoint Development Committee\u201d or \u201cJDC\u201d), which shall have the responsibilities set forth in Section 2.2(b). Each Party shall initially appoint three (3) representatives to the JDC, with each representative having knowledge and expertise in the development of Molecules and products similar to the Arcus Molecules, Arcus Products, Optioned Molecules and Optioned Products and having sufficient seniority within such Party to make decisions arising within the scope of the JDC\u2019s responsibilities. The JDC may change its size from time to time if agreed by consensus among its members; provided that the JDC shall consist at all times of an equal number of representatives of each of Arcus and Gilead. Each Party may replace its JDC representatives at any time upon written notice to the other Party. Either Party may invite non-members to participate in the discussions and meetings of the JDC with the other Party\u2019s prior approval, such approval not to be unreasonably conditioned, withheld or delayed and such non-members shall (i) be subject to confidentiality obligations at least as stringent as those set forth in ARTICLE XIII and (ii) have no voting authority at the JDC. The JDC shall have a chairperson, who shall serve for a term of one (1) year, and who shall be selected alternately, on an annual basis, by Arcus or Gilead. The initial chairperson shall be selected by [***]. The role of the chairperson shall be to convene and preside at meetings of the JDC, but the chairperson shall have no additional powers or rights beyond those held by the other JDC representatives.", "hash": "65d5e29dba5dd898aa27afe7a1b2eccd", "id": 6}, {"size": 5, "samples": [{"hash": "y0mcdNrzea", "uri": "/contracts/y0mcdNrzea#formation-composition", "label": "Supply Agreement (Mannkind Corp)", "score": 32.1512680054, "published": true}, {"hash": "hZmyR02cN4i", "uri": "/contracts/hZmyR02cN4i#formation-composition", "label": "Supply Agreement", "score": 31.3408622742, "published": true}, {"hash": "k0n4ksF2t7L", "uri": "/contracts/k0n4ksF2t7L#formation-composition", "label": "Supply Agreement (Mannkind Corp)", "score": 25.8569469452, "published": true}], "snippet_links": [{"key": "the-parties-shall", "type": "clause", "offset": [0, 17]}, {"key": "a-team", "type": "definition", "offset": [23, 29]}, {"key": "responsible-for", "type": "clause", "offset": [63, 78]}, {"key": "activities-under-this-agreement", "type": "clause", "offset": [96, 127]}, {"key": "each-party", "type": "clause", "offset": [129, 139]}, {"key": "the-project-team", "type": "clause", "offset": [157, 173]}, {"key": "number-of", "type": "definition", "offset": [183, 192]}, {"key": "requisite-skills", "type": "clause", "offset": [220, 236]}, {"key": "performance-of-activities", "type": "clause", "offset": [270, 295]}, {"key": "project-team-members", "type": "clause", "offset": [344, 364]}, {"key": "at-any-time", "type": "clause", "offset": [365, 376]}, {"key": "notice-to-the", "type": "clause", "offset": [388, 401]}], "snippet": "The Parties shall form a team (\u201cProject Team\u201d), which shall be responsible for oversight of the activities under this Agreement. Each Party shall appoint to the Project Team an equal number of team members that have the requisite skills in the disciplines necessary for performance of activities under this Agreement. Each Party may change its Project Team members at any time by written notice to the other.", "hash": "0fc53e7a7eca0097470c7fffe16064b5", "id": 7}, {"size": 4, "samples": [{"hash": "g8SGAIgxEFx", "uri": "/contracts/g8SGAIgxEFx#formation-composition", "label": "Option and License Agreement (Artiva Biotherapeutics, Inc.)", "score": 35.4887046814, "published": true}, {"hash": "3Y8obszIwHD", "uri": "/contracts/3Y8obszIwHD#formation-composition", "label": "Option and License Agreement (Artiva Biotherapeutics, Inc.)", "score": 35.3353881836, "published": true}, {"hash": "efpjRdRRzUV", "uri": "/contracts/efpjRdRRzUV#formation-composition", "label": "Option and License Agreement (Artiva Biotherapeutics, Inc.)", "score": 32.266254425, "published": true}], "snippet_links": [{"key": "after-the-effective-date", "type": "clause", "offset": [21, 45]}, {"key": "the-parties-shall", "type": "clause", "offset": [47, 64]}, {"key": "joint-research-steering-committee", "type": "definition", "offset": [77, 110]}, {"key": "representatives-of", "type": "clause", "offset": [181, 199]}, {"key": "such-party", "type": "clause", "offset": [347, 357]}, {"key": "jsc-representatives", "type": "clause", "offset": [413, 432]}, {"key": "at-any-time", "type": "clause", "offset": [465, 476]}, {"key": "upon-written-notice", "type": "clause", "offset": [477, 496]}, {"key": "each-party", "type": "clause", "offset": [508, 518]}, {"key": "notice-to-the", "type": "clause", "offset": [580, 593]}, {"key": "other-party", "type": "definition", "offset": [594, 605]}], "snippet": "Within ten (10) days after the Effective Date, the Parties shall establish a Joint Research Steering Committee (\u201cJSC\u201d) composed of five (5) representatives, consisting of three (3) representatives of GCLC and two (2) representatives of Artiva, each of whom shall have appropriate technical credentials, experience, knowledge, and authority within such Party\u2019s organization. The JSC shall be chaired by one of the JSC representatives of GCLC, which GCLC may replace at any time upon written notice to Artiva. Each Party may replace its JSC representatives at any time upon written notice to the other Party.", "hash": "ba32f0e497c9f4725cf62c8188a4fcc3", "id": 8}, {"size": 4, "samples": [{"hash": "frcVjxXfl3l", "uri": "/contracts/frcVjxXfl3l#formation-composition", "label": "Collaboration and License Agreement (Anchiano Therapeutics Ltd.)", "score": 32.0335388184, "published": true}, {"hash": "1qzwMa4VN6H", "uri": "/contracts/1qzwMa4VN6H#formation-composition", "label": "Collaboration and License Agreement (Anchiano Therapeutics Ltd.)", "score": 30.7248458862, "published": true}], "snippet_links": [{"key": "after-the-effective-date", "type": "clause", "offset": [9, 33]}, {"key": "the-parties-will", "type": "clause", "offset": [35, 51]}, {"key": "joint-steering-committee", "type": "clause", "offset": [64, 88]}, {"key": "comprised-of", "type": "definition", "offset": [131, 143]}, {"key": "each-party", "type": "clause", "offset": [174, 184]}, {"key": "representatives-of", "type": "clause", "offset": [199, 217]}, {"key": "affiliate-of", "type": "definition", "offset": [221, 233]}, {"key": "such-party", "type": "clause", "offset": [234, 244]}, {"key": "applicable-party", "type": "definition", "offset": [283, 299]}, {"key": "scope-of-the", "type": "clause", "offset": [337, 349]}, {"key": "from-time-to-time", "type": "clause", "offset": [402, 419]}, {"key": "consent-of", "type": "clause", "offset": [433, 443]}, {"key": "provided-that", "type": "definition", "offset": [457, 470]}, {"key": "at-all-times", "type": "definition", "offset": [492, 504]}, {"key": "number-of-representatives", "type": "clause", "offset": [517, 542]}, {"key": "jsc-representatives", "type": "clause", "offset": [599, 618]}, {"key": "at-any-time", "type": "clause", "offset": [619, 630]}, {"key": "notice-to-the", "type": "clause", "offset": [644, 657]}, {"key": "other-party", "type": "definition", "offset": [658, 669]}, {"key": "core-members", "type": "definition", "offset": [694, 706]}, {"key": "participate-in", "type": "definition", "offset": [710, 724]}, {"key": "meetings-of-the-jsc", "type": "clause", "offset": [745, 764]}, {"key": "voting-authority", "type": "clause", "offset": [811, 827]}, {"key": "subject-to", "type": "clause", "offset": [867, 877]}, {"key": "confidentiality-obligations", "type": "clause", "offset": [878, 905]}, {"key": "confidentiality-agreement", "type": "clause", "offset": [920, 945]}, {"key": "role-of-the", "type": "clause", "offset": [1092, 1103]}, {"key": "additional-powers", "type": "clause", "offset": [1202, 1219]}, {"key": "alliance-managers", "type": "definition", "offset": [1286, 1303]}, {"key": "will-work", "type": "clause", "offset": [1304, 1313]}, {"key": "to-ensure", "type": "clause", "offset": [1373, 1382]}, {"key": "preparation-of", "type": "clause", "offset": [1387, 1401]}], "snippet": "Promptly after the Effective Date, the Parties will establish a joint steering committee (the \u201cJoint Steering Committee\u201d or \u201cJSC\u201d) comprised of four (4) representatives from each Party (or appointed representatives of an Affiliate of such Party) with sufficient seniority within the applicable Party to make decisions arising within the scope of the JSC\u2019s responsibilities. The JSC may change its size from time to time by unanimous consent of its members, provided that the JSC will consist at all times of an equal number of representatives of each of ADT and Anchiano. Each Party may replace its JSC representatives at any time upon written notice to the other Party. The JSC may invite non-core members to participate in the discussions and meetings of the JSC, provided that such participants will have no voting authority at the JSC and shall, if not otherwise subject to confidentiality obligations, enter into a confidentiality agreement reasonably acceptable to the Parties. Each meeting of the JSC will be co-chaired by a representative of ADT and a representative of Anchiano. The role of the chairpersons will be to convene and preside at meetings of the JSC. The chairpersons will have no additional powers or rights beyond those held by the other JSC representatives. The Alliance Managers will work with the chairpersons to prepare and circulate agendas and to ensure the preparation of minutes.", "hash": "8e2a53f2d288fb2d560a624e7066329f", "id": 9}, {"size": 4, "samples": [{"hash": "g8SGAIgxEFx", "uri": "/contracts/g8SGAIgxEFx#formation-composition", "label": "Option and License Agreement (Artiva Biotherapeutics, Inc.)", "score": 35.4887046814, "published": true}, {"hash": "3Y8obszIwHD", "uri": "/contracts/3Y8obszIwHD#formation-composition", "label": "Option and License Agreement (Artiva Biotherapeutics, Inc.)", "score": 35.3353881836, "published": true}], "snippet_links": [{"key": "after-the-effective-date", "type": "clause", "offset": [21, 45]}, {"key": "the-parties-shall", "type": "clause", "offset": [47, 64]}, {"key": "joint-development-steering-committee", "type": "clause", "offset": [77, 113]}, {"key": "representatives-of", "type": "clause", "offset": [184, 202]}, {"key": "such-party", "type": "clause", "offset": [350, 360]}, {"key": "the-jdc", "type": "clause", "offset": [377, 384]}, {"key": "at-any-time", "type": "clause", "offset": [458, 469]}, {"key": "upon-written-notice", "type": "clause", "offset": [470, 489]}, {"key": "each-party", "type": "clause", "offset": [499, 509]}, {"key": "notice-to-the", "type": "clause", "offset": [571, 584]}, {"key": "other-party", "type": "definition", "offset": [585, 596]}], "snippet": "Within ten (10) days after the Effective Date, the Parties shall establish a Joint Development Steering Committee (\u201cJDC\u201d) composed of five (5) representatives, consisting of three (3) representatives of Artiva and two (2) representatives of GCLC, each of whom shall have appropriate technical credentials, experience, knowledge, and authority within such Party\u2019s organization. The JDC shall be chaired by a representative of Artiva, which \u2587\u2587\u2587\u2587\u2587\u2587 may replace at any time upon written notice to GCLC. Each Party may replace its JDC representatives at any time upon written notice to the other Party.", "hash": "db8a40fda117120e20764e91cef18bc7", "id": 10}], "next_curs": "Cl4SWGoVc35sYXdpbnNpZGVyY29udHJhY3RzcjoLEhZDbGF1c2VTbmlwcGV0R3JvdXBfdjU2Ih5mb3JtYXRpb24tY29tcG9zaXRpb24jMDAwMDAwMGEMogECZW4YACAA", "clause": {"parents": [["governance", "Governance"], ["joint-steering-committee", "Joint Steering Committee"], ["joint-development-committee", "Joint Development Committee"], ["joint-commercialization-committee", "Joint Commercialization Committee"], ["joint-manufacturing-committee", "Joint Manufacturing Committee"]], "size": 103, "children": [["joint-steering-committee", "Joint Steering Committee"], ["joint-marketing-committee", "Joint Marketing Committee"], ["joint-alliance-committee", "Joint Alliance Committee"]], "title": "Formation; Composition", "id": "formation-composition", "related": [["formation-and-composition", "Formation and Composition", "Formation and Composition"], ["board-composition", "Board Composition", "Board Composition"], ["committee-composition", "Committee Composition", "Committee Composition"], ["manufacturing", "Manufacturing", "Manufacturing"], ["compositions", "Compositions", "Compositions"]], "related_snippets": [], "updated": "2026-05-10T05:39:37+00:00", "also_ask": ["What minimum requirements should be included to ensure valid formation under applicable law?", "How can the composition terms be structured to maximize client control or influence?", "What are the most common pitfalls or ambiguities in defining composition that courts have flagged?", "How does this clause compare to standard formation/composition provisions in similar agreements?", "What evidence is typically required to prove proper formation and composition if challenged in court?"], "drafting_tip": "Specify the entity's formation process to ensure legal validity; detail composition requirements to clarify governance structure; reference applicable laws to ensure compliance.", "explanation": "The 'Formation; Composition' clause defines how and when a contract is considered legally formed and specifies the parties and documents that make up the agreement. It typically outlines the requirements for acceptance, such as signatures or other forms of assent, and may list any schedules, exhibits, or referenced documents that are incorporated into the contract. This clause ensures that all parties are clear on what constitutes the complete agreement and helps prevent disputes over whether a binding contract exists or what documents are included."}, "json": true, "cursor": ""}}